In humans, increased amounts of MSI2 correlate with poor prognosis of leukemia—indicating that MSI2 may be a target to treat this type of cancer. Normal blood is composed of several cell types.

Chronic myelomonocytic leukemia (CMML) is a rare type of blood ... Most people have under 5% blast cells among the developing blood cells in their bone marrow and none in their blood.

Acute lymphoblastic leukemia (ALL) is a form of leukemia, or cancer of the white blood cells characterized by ... in a relatively immature (also termed 'blast') state. Science X Daily and the ...

Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

The clinical characteristics of the chronic phase are described above, and are chiefly manifestations of the excess of white blood cells in the ... accelerated phase or blast crisis.

More than 400 people, 80% of them being children under 14 years old, will be diagnosed with B-cell Acute Lymphoblastic Leukemia (B-ALL) next year in Spain, according to the latest projections from ...

[87,88,89] The utility of cord blood transplants for adult recipients is presently limited by the number of stem cells in each cord ... for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 ...

The drug improves bone marrow function by freeing up the genes the body needs to make normal blood cells. When bone marrow function improves, blood counts increase. For some people, the blast count in ...